| ACR20 | American College of Rheumatology Criteria for 20% Improvement |
| DB | Double-Blind |
| DC | Dendritic Cells |
| NK | Natural Killer |
| DLQI | Dermatology Quality of Life Index |
| PASI | Psoriasis Area and Severity Index |
| PC | Placebo-Controlled |
| ACR20 | American College of Rheumatology Criteria for 20% Improvement |
| DB | Double-Blind |
| DC | Dendritic Cells |
| NK | Natural Killer |
| DLQI | Dermatology Quality of Life Index |
| PASI | Psoriasis Area and Severity Index |
| PC | Placebo-Controlled |